Application of cDNA microarrays to examine gene expression differences in schizophrenia
- 1 July 2001
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 55 (5) , 641-650
- https://doi.org/10.1016/s0361-9230(01)00522-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Brain 14‐3‐3 protein is an activator protein that activates tryptophan 5‐monooxygenase and tyrosine 3‐monooxygenase in the presence of Ca2+,calmodulin‐dependent protein kinase IIPublished by Wiley ,2001
- Clinical Features of Schizophrenia and Linkage to Chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia FamiliesAmerican Journal of Psychiatry, 2000
- Stability of RNA transcripts in post-mortem psychiatric brainsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Expression profiling using cDNA microarraysNature Genetics, 1999
- Localization of CAM II Kinase-α, GAD, GluR2 and GABAA Receptor Subunit mRNAs in the Human Entorhinal CortexEuropean Journal of Neuroscience, 1997
- Structural Organization and Chromosomal Assignment of the Human 14-3-3 η Chain Gene (YWHAH)Genomics, 1996
- Serial Analysis of Gene ExpressionScience, 1995
- Pre‐and Postmortem Influences on Brain RNAJournal of Neurochemistry, 1993
- cDNA cloning and chromosome assignment of the gene for human brain 14–3–3 protein η chainJournal of Neuroscience Research, 1992
- Widespread Distribution of the 14-3-3 Protein in Vertebrate Brains and Bovine Tissues: Correlation with the Distributions of Calcium-Dependent Protein KinasesJournal of Neurochemistry, 1991